第32回　日本肝胆膵外科学会　2021年2月

別府 透：大腸癌多発肝転移における外科的治療戦略　シンポジウム3　Overview

赤星 慎一：Multidisciplinary treatment for unresectable hepatocellular carcinoma using Lenvatinib

山村 謙介：Morphological Changes of Remnant Pancreas and Fatty Liver after Pancreaticoduodenectomy

第33回　日本内視鏡外科学会総会　2021年3月

山村 謙介：Standardization of laparoscopic distal pancreatectomy for pancreatic cancer

第57回　日本肝臓学会総会　2021年6月

山村 謙介：肝切除後の門脈血栓発生のリスク解析と治療に関する前向き検討

第121回　日本外科学会定期学術集会　2021年4月

井上 惠二朗（地域研修学生）：閉塞性黄疸を伴うB4肝細胞癌の根治手術例の経験

織田 枝里：術前の血小板増加は肝細胞癌切除例における予後不良因子である

佐藤 伸隆：高齢者虫垂炎症例におけるInterval appendectomyの有用性　～当科治療方針の検証～

山村 謙介：肝切除後の門脈血栓症危険因子の前向き検討

赤星 慎一：当院における腹腔鏡下鼠径ヘルニア修復術（TEP）の導入後の手術成績

第33回　日本肝胆膵外科学会　2021年6月

Symposium 5 Keynote lecture
Beppu T: Multidisciplinary treatment for multiple colorectal liver metastases considering possibility of liver resection

第76回　日本消化器外科学会総会　2021年7月

原 淑大：FIB4-indexによる胃癌肝転移予測と予後との関連

織田 枝里：外科医が性別にかかわらずに家庭運営に携わるための工夫について

山村 謙介：肝切除後の門脈血栓発生のリスク解析と治療に関する前向き検討

赤星 慎一：地方基幹病院での働き方改革の実情と課題 ―コメディカルの視点―

別府 透：一般演題　肝臓:転移2（座長）

A-PHPBA 2021 Bali - Virtual Congress 2021年4月

Symposium Liver 1 – CRLM
Beppu T: Timing of surgery for colorectal liver metastases considering possibility of liver resection

ACTA 2021 TOKYO 2021年10月

IS3 : Ablation of Colorectal Liver Metastasis
Beppu T (Chair)
Beppu T: Thermal ablation in the multidisciplinary treatment for patients with initially unresectable colorectal liver metastases

第57回　日本胆道学会学術集会　2021年10月

原 淑大：胆嚢腫瘍を契機に診断された原発不明癌多発肝転移の1例

山村 謙介：胆管空腸吻合術後に発症した腹腔内出血を伴う肝炎症性偽腫瘍の1例

別府 透：口演59　肝内胆管癌2（座長）

32nd World Congress of International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) 2021 2021年10月

Symposium
Beppu T: Treatment strategy for multiple colorectal liver metastases considering the possibility of liver resection (invited speaker)

第83回日本臨床外科学会総会 2021年11月

原 淑大：細胆管癌切除後の3回の再発に対して肝切除とラジオ波焼灼術の反復施行が有用であった1例

第19回　日本消化器外科学会大会（第29回 JDDW） 2021年11月

山村 謙介：腹腔内出血が診断契機となった肝炎症性偽腫瘍の１例

織田 枝里：膵神経内分泌腫瘍の肝転移が疑われ切除後に判明した肝内胆管癌と胆管腺腫が混在した1例

赤星 慎一：腸管内implantationが原因で早期に再発したと思われるPD-L1陽性大腸腺扁平上皮癌の1例

第42回　九州肝臓外科研究会 学術集会

別府　透：主題 1.肝切除周術期の分子標的薬使用の経験（座長）

山村　謙介: 主題 3．技術の伝承・こだわりの教育法. 『長期予後を見据えた B4 肝細胞癌の治療戦略』の伝承

別府　透

山村　謙介

赤星　慎一

織田　枝里

消化器内科　本原 利彦

栄養管理室　永田 美華

薬剤科　森 まりえ

薬剤科　森 まりえ

1st author

1. Matsumura Y, Yamamura K, Miyamoto H, Hara Y, Oda E, Akahoshi S, Yoshida K, Yuki H, Motohara T, Sakamoto K, Komohara Y, Beppu T. Highly advanced colorectal liver metastases successfully treated with fluorouracil plus leucovorin monotherapy and microwave ablation. Anticancer Res. 2022
   Mar;42(3):1645-1651. doi: 10.21873/anticanres.15641. PMID: 35220264
2. Hara Y, Yamamura K, Matsumura K, Oda E, Akahoshi S, Yuki H, Tomiguchi J, Motohara T, Miyamoto H, Komohara Y, Beppu T. Laparoscopic Surgery for a Patient With Multiple Liver Metastases of Unknown Origin Concomitant With Gallbladder Tumor. In Vivo. 2021 Sep-Oct;35(5):2963-2968. doi: 10.21873/invivo.12590. PMID: 34410995
3. Oda E, Yamamura K, Hara Y, Matsumura K, Akahoshi S, Yuki H, Tomiguchi J, Motohara T, Miyamoto H, Kinoshita K, Matsumura F, Ohnishi K, Komohara Y, Beppu T. Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor. Anticancer Res. 2021 Oct;41(10):5249-5254. doi: 10.21873/anticanres.15344. PMID: 34593478
4. Yamamura K, Beppu T, BabaH. Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. Ann Gastroenterol Surg (in press).
5. Yamamura K, Beppu T, Miyata T, Okabe H, Nitta H, Imai K, Hayashi H, Akahoshi S. Conversion surgery for hepatocellular carcinoma following molecular therapy. Anticancer Res. 2022 Jan;42(1):35-44. doi: 10.21873/anticanres.15454. PMID: 34969706
6. Yamamura K, Beppu T, Conversion surgery for hepatocellular carcinoma after multidisciplinary treatment including lenvatinib. Hepatol Res. 2021 Oct;51(10):1029-1030. doi: 10.1111/hepr.13691. PMID: 34596312
7. Yamamura K, Beppu T, Sato N, Oda E, Kinoshita K, Yuki H, Motohara T, Miyamoto H, Oda T, Akahoshi S. Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report. Clin J Gastroenterol. 2021 Feb;14(1):251-257. doi: 10.1007/s12328-020-01286-2. Epub 2020 Nov 12. PMID: 33180262
8. Yamamura K, Beppu T, Oda E, Sato N, Yuki H, Motohara T, Miyamoto H, Miyamura S, Onishi K, Komohara Y, Akahoshi S. Hepatic Inflammatory Pseudotumor Mimicking Malignant Tumor With Rare Onset of Intra-abdominal Hemorrhage. Anticancer Res. 2021 May;41(5):2727-2732. doi: 10.21873/anticanres.15054. PMID: 33952504
9. Akahoshi S, Yamamura K, Komohara Y, Sato N, Oda E, Yuki H, Yoshii D, Beppu T. A Case Report of Metachronous Multiple Adenosquamous Carcinoma of the Colon Over-expressing PD-L1 and a Literature Review. Anticancer Res. 2021 Nov;41(11):5847-5854. doi: 10.21873/anticanres.15404. PMID: 34732461
10. Beppu T, Yamamura K, Okabe H, Imai K, Hayashi H. Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Ann Gastroenterol Surg. 2020 Dec 13;5(3):287-295. doi: 10.1002/ags3.12414. eCollection 2021 May. PMID: 34095718
11. Beppu T, Imai K, Honda G, Sakamoto K, Kobayashi S, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Yamaguchi T, Tabuchi K, Kobayashi H, Yamaguchi K, Morita S, Kikuchi K, Miyazaki M, Sugihara K, Yamamoto M, Takahashi K; Joint Committee for Nationwide Survey on Colorectal Liver Metastasis. Proposal of a novel H category-based classification of colorectal liver metastases based on a Japanese nationwide survey. J Hepatobiliary Pancreat Sci. 2021 Apr;28(4):317-326. doi: 10.1002/jhbp.920. Epub 2021 Mar 16. PMID: 33609318
12. Beppu T, Yamamura K, Okabe H, Miyata T, Kitano Y, Imai K, Hayashi H, Akahoshi S. Management of Future Liver Remnant: Strategies to Promote Hepatic Hypertrophy. Hepatoma Res. 2021;7:64. DOI: 10.20517/2394-5079.2021.49
13. Adachi Y, Yamamura K, Yumoto S, Higashi T, Ishiodori H, Honda S, Hara Y, Matsumura K, Oda E, Akahoshi S, Yuki H, Miyamoto H, Doi K, Beppu T. Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy. Anticancer Res. 2021 Nov;41(11):5855-5861. doi: 10.21873/anticanres.15405. PMID: 34732462

3rd author以降

1. Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Takako NE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. Hepatobiliary Pancreat Sci. 2021 Jan;28(1):1-25. doi: 10.1002/jhbp.868. Epub 2020 Dec 12. PMID: 33200538
2. Qian T, Fujiwara N, Koneru B, Ono A, Kubota N, Jajoriya AK, Tung MG, Crouchet E, Song WM, Marquez CA, Panda G, Hoshida A, Raman I, Li QZ, Lewis C, Yopp A, Rich NE, Singal AG, Nakagawa S, Goossens N, Higashi T, Koh AP, Bian CB, Hoshida H, Tabrizian P, Gunasekaran G, Florman S, Schwarz ME, Hiotis SP, Nakahara T, Aikata H, Murakami E, Beppu T, Baba H, Rew Warren, Bhatia S, Kobayashi M, Kumada H, Fobar AJ, Parikh ND, Marrero JA, Rwema SH, Nair V, Patel M, Kim-Schulze S, Corey K, O'Leary JG, Klintmalm GB, Thomas DL, Dibas M, Rodriguez G, Zhang B, Friedman SL, Baumert TF, Fuchs B, Chayama K, Zhu S, Chung RT, Hoshida Y. Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development. Gastroenterology. 2021 Dec 22:S0016-5085(21)04086-5. doi: 10.1053/j.gastro.2021.12.250. Online ahead of print. PMID: 34951993
3. Miyata T, Hayashi H, Yamashita YI, Matsumura K, Higashi T, Imai K, Nitta H, Chikamoto A, Beppu T, Baba H. ASO Visual Abstract: The Impact of Histological Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Ann Surg Oncol. 2022 Feb;29(2):893-902. doi: 10.1245/s10434-021-10706-7. Epub 2021 Sep 30. PMID: 34595665
4. Miyata T, Yamashita YI, Arima K, Higashi T, Hayashi H, Imai K, Nitta H, Chikamoto A, Beppu T, Baba H. Alteration of prognostic efficacy of albumin-bilirubin grade and Child-Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child-Pugh A following hepatectomy. Ann Gastroenterol Surg. 2021 Sep 19;6(1):127-134. doi: 10.1002/ags3.12498. eCollection 2022 Jan. PMID: 35106423

第41回 九州肝臓外科研究会　2020年1月

別府透：AP-shuntを伴う巨大肝癌に対するTACE、lenvatinib投与後のconversion肝切除

第42回 日本癌局所療法研究会　2020年5月

赤星慎一：大腸腺扁平上皮癌の１切除例

第120回 日本外科学会定期学術集会　2020年8月

木下浩一：肝切除後の門脈血栓症の前向き検討

山村謙介：当科における膵空腸吻合法の変遷と短期成績―Blumgart変法の有用性の検討―

第18回 日本消化器外科学会大会（第28回 JDDW）　2020年11月

山村謙介:Gene signatureを用いた非B非C型肝細胞癌の再発予測ノモグラムの樹立

織田枝里:肝嚢胞より発生し、悪性腫瘍を疑った黄色肉芽種の1切除例

第14回 肝臓内視鏡外科研究会　2020年11月

別府透：要望演題２「HALS の適応と方法・コンバージョンのタイミング」(ディスカッサント)

第75回 日本消化器外科学会総会　2020年12月

佐藤伸隆：切除不能肝細胞癌症例に対するLenvatinib療法における部分的脾塞栓術の有用性

山村謙介：膵癌に対する腹腔鏡下尾側切除術の導入－手技の定型化と短期成績－

赤星慎一：地域中核病院での同時性肝転移を伴う大腸癌に対する同時手術の検討

別府透：一般演題：肝転移3　（座長）

第45回 日本外科連合学会　2020年12月

山村謙介：膵頭十二指腸切除後の残膵萎縮の長期的解析と、膵消化管吻合法による脂肪肝発症のリスク分析

別府透：パネルディスカッション5　両葉多発肝転移に対する肝切除戦略　特別発言

第56回 日本肝癌研究会　2020年12月

別府透：ワークショップ1　高度進行肝細胞癌に対する集学的治療の展開

別府透：ワークショップ5　転移性肝癌の治療戦略　特別発言

第32回日本肝胆膵外科学会　2021年2月

別府透：シンポジウム3　大腸癌多発肝転移における外科的治療戦略　Overview

赤星慎一：Multidisciplinary treatment for unresectable hepatocellular carcinoma using Lenvatinib

山村謙介：Morphological Changes of Remnant Pancreas and Fatty Liver after Pancreaticoduodenectomy

第33回 日本内視鏡外科学会総会　2021年3月

山村謙介：Standardization of laparoscopic distal pancreatectomy for pancreatic cancer

別府　透

佐藤　伸隆

山村　謙介

First and 2nd author

1. Yamamura K, Beppu T, Sato N, Oda E, Kinoshita K, Yuki H, Motohara T, Miyamoto H, Oda T, Akahoshi S. Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report. Clin J Gastroenterol. 2021 Feb;14(1):251-257. doi: 10.1007/s12328-020-01286-2. Epub 2020 Nov 12. PMID: 33180262
2. Beppu T, Yamamura K, Okabe H, Imai K, Hayashi H. Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Ann Gastroenterol Surg (in press)
3. Beppu T, Imai K, Honda G, Sakamoto K, Kobayashi S, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Yamaguchi T, Tabuchi K, Kobayashi H, Yamaguchi K, Morita S, Kikuchi K, Miyazaki M, Sugihara K, Yamamoto M, Takahashi K; Joint Committee for Nationwide Survey on Colorectal Liver Metastasis. Proposal of a novel H category-based classification of colorectal liver metastases based on a Japanese nationwide survey. JBeppu T, Imai K, Honda G, Sakamoto K, Kobayashi S, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Yamaguchi T, Tabuchi K, Kobayashi H, Yamaguchi K, Morita S, Kikuchi K, Miyazaki M, Sugihara K, Yamamoto M, Takahashi K; Joint Committee for Nationwide Survey on Colorectal Liver Metastasis. Proposal of a novel H category-based classification of colorectal liver metastases based on a Japanese nationwide survey. J Hepatobiliary Pancreat Sci. 2021 Feb 20. doi: 10.1002/jhbp.920. Online ahead of print. PMID: 33609318
4. Yamamura K, Beppu T, Kinoshita K, Oda E, Sato N, Yuki H, Motohara T, Miyamoto H, Kawaguchi H, Komohara Y, Akahoshi S. Hepatocellular carcinoma with extensive cancer-associated thrombosis successfully treated with liver resection and direct oral anticoagulant: a case report. Anticancer Res. 2020 Nov;40(11):6465-6471. doi: 10.21873/anticanres.14668. PMID: 33109585
5. Yamamura K, Beppu T, Sato N, , Kinoshita K, Oda E, Yuki H, Motohara T, Miyamoto H, Komohara Y, Beppu T, Akahoshi S. Complete removal of adrenal metastasis in hepatocellular carcinoma using indocyanine green fluorescent imaging. Anticancer Res. 2020 Oct;40(10):5823-5828. doi: 10.21873/anticanres.14600. PMID: 32988911
6. Akahoshi S, Beppu T, Mori Y, Kinoshita K, Sato N, Kikuchi K. Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection? Hepatobiliary Surg Nutr, 2020;9(5):657-660.
7. Akahoshi S, Yamamura K, Sato N, Eri Oda, Kinoshita K A, Yuki H, Motohara T, Deguchi A, Komohara Y, Beppu T. A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography. Clin J Gastroenterol 2020 Jul 23. doi: 10.1007/s12328-020-01194-5. PMID: 32705537
8. Oda E, Beppu T, Kinoshita K, Yamamura K, Sato N, Yuki H, Chiyonaga S, Motohara T, Komohara Y, Akahoshi S. Hepatic xanthogranuloma that originated from a liver cyst and mimicked a malignant tumor. In Vivo 2020 Jul-Aug;34(4):2067-2071. doi: 10.21873/invivo.12009. PMID: 32606184
9. Sato N, Yamamura K, Oda E, Akahoshi S, Yuki H, Motohara T, Miyamoto H, Yoshii D, Komohara Y, Beppu T. Cholangiolocarcinoma with multiple recurrences cholangiolocarcinoma with multiple recurrences successfully treated with repeated liver resection and radiofrequency ablation. Anticancer Res 2020 Dec;40(12):7147-7153. doi: 10.21873/anticanres.14745. PMID: 33288615
10. Sato N, Beppu T, Oda E, Yamamura K, Akahoshi S. Conversion surgery for hepatocellular carcinoma with lenvatinib. Arch Gastroenterol Res 2020
11. Kobayashi S, Beppu T, Honda G, Yamamoto M, Takahashi K, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Sakamoto K, Yamaguchi T, Morita S, Tabuchi K, Miyazaki M, Sugihara K. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey. J Gastrointest Surg. 2020 Jun;24(6):1244-1260. doi: 10.1007/s11605-019-04250-9. PMID: 31197683
12. Kaida T, Beppu T, Hayashi H, Imai K, Yamamura K, Okabe H, Matsumura K, Yoshii D, Komohara Y, Akahoshi S, Doi K, Yamashita YI, Baba H. Inflammatory Liver Tumor Caused by Fasciola hepatica Mimicking Intrahepatic Cholangiocarcinoma. Anticancer Res. 2020 May;40(5):2795-2800. doi: 10.21873/anticanres.14252. PMID: 32366426

3rd author以降

1. Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Takako NE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci. 2021 Jan;28(1):1-25. doi: 10.1002/jhbp.868. Epub 2020 Dec 12. PMID: 33200538
2. Qin J, Higashi T, Nakagawa S, Yamashita YI, Beppu T, Baba H, Kobayashi M, Kumada H, Gunasekaran G, Schiano TD, Thung SN, Fiel MI, Hoshida Y, Ward SC.　Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights. Am J Surg Pathol. 2020 Jun 30. doi: 10.1097/PAS.0000000000001533. Online ahead of print.　PMID: 32618599
3. Hidaka M, Eguchi S, Okuda K, Beppu T, Shirabe K, Kondo K, Takami Y, Ohta M, Shiraishi M, Ueno S, Nanashima A, Noritomi T, Kitahara K, Fujioka H. Impact of Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion (vp1): A Multi-institutional Study by the Kyushu Study Group of Liver Surgery. Ann Surg. 2020 Feb;271(2):339-346.
4. Sakamoto K, Honda G, Beppu T, Kotake K, Yamamoto M, Takahashi K, Endo I, Hasegawa K, Itabashi M, Hashiguchi Y, Kotera Y, Kobayashi S, Yamaguchi T, Tabuchi K, Kobayashi H, Yamaguchi K, Morita S, Miyazaki M, Sugihara K. Comprehensive data of 3,525 patients newly diagnosed with colorectal liver metastasis between 2013 and 2014: 2nd report of a nationwide survey in Japan. J Hepatobiliary Pancreat Sci. 2020 Apr 13. doi: 10.1002/jhbp.738. [Epub ahead of print] PMID: 32281742
5. Yamashita YI, Aishima S, Nakao Y, Yoshizumi T, Nagano H, Kuroki T, Takami Y, Ide T, Ohta M, Takatsuki M, Nanashima A, Ishii F, Kitahara K, Iino S, Beppu T, Baba H, Eguchi S. Clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma from the viewpoint of patient prognosis after hepatic resection: High rate of early recurrence and its predictors. Hepatol Res. 2020 Jul;50(7):863-870. doi: 10.1111/hepr.13507. [Epub ahead of print] PMID: 32335986
6. Hayashi H, Yamashita YI, Okabe H, Imai K, Higashi T, Yamamura K, Chikamoto A, Beppu T, Takamori H, Baba H. Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy. PLoS One. 2020 Jun 19;15(6):e0234919. doi: 10.1371/journal.pone.0234919. eCollection 2020. PMID: 32559223
7. Nitta H, Kitano Y, Miyata T, Nakagawa S, Mima K, Okabe H, Hayashi H, Imai K, Yamashita YI, Chikamoto A, Beppu T, Baba H. Validation of Functional Assessment for Liver Resection Considering Venous Occlusive Area after Extended Hepatectomy. J Gastrointest Surg. 2020 Jul;24(7):1510-1519. doi: 10.1007/s11605-019-04234-9. Epub 2019 May 29. PMID: 31144188
8. Sawada Y, Sahara K, Endo I, Sakamoto K, Honda G, Beppu T, Kotake K, Yamamoto M, Takahashi K, Hasegawa K, Itabashi M, Hashiguchi Y, Kotera Y, Kobayashi S, Yamaguchi T, Tabuchi K, Kobayashi H, Yamaguchi K, Morita S, Natsume S, Miyazaki M, Sugihara K. Long-term outcome of liver resection for colorectal metastases in the presence of extrahepatic disease: A multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2020 Jul 26. doi: 10.1002/jhbp.810. PMID: 32713080

第119回日本外科学会定期学術集会　2019年4月

木下浩一：地域中核病院における大腸癌同時性肝転移に対する腹腔鏡下の大腸・肝同時手術の導入

赤星慎一：直腸癌に対する低位前方切除術における手術侵襲および術後合併症と予後の関連

The 2nd World Congress of the International Laparoscopic Liver Society (ILLS2019) 2019. 5

Beppu T: Oral Session 3 (Chair)

第55回日本肝臓学会2019年5月

別府　透：セッション13　肝疾患診断2（座長）

The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery （第31回　日本肝胆膵外科学会）　2019.6

Beppu T: Minimal requirements of hemihepatectomy for board-certified HBP surgeons (Educational video)
Beppu T: International clinical practice guidelines for metastatic liver tumors: An interim report on colorectal liver metastases (Special lecture)

第41回癌局所療法研究会　2019年6月

佐藤伸隆：部分的脾塞栓術が集学的治療の継続に大きく貢献した大腸癌多発肝転移の一例

木下浩一：様々なアプローチの局所凝固療法と化療で長期生存が得られている大腸癌肝転移の一例

第74回日本消化器外科学会総会　2019年7月

別府　透：要望演題31　蛍光観察による消化器外科手術のメリット1（座長）

佐藤伸隆：部分的脾塞栓術の新しい展開

赤星慎一：再発大腸癌に対する治療戦略

31th Anniversary IASGO World Congress, Bangkok, Thailand on October 3-5, 2019

Beppu T: Multidisciplinary treatment for colorectal liver metastases with special attention to ablation therapy (invited lecture)

第57回日本癌治療学会学術集会

別府　透：JSCO/JHBPS　ジョイントシンポジウム

転移性肝癌国際診療ガイドライン公聴会

『転移性肝癌国際診療ガイドライン－大腸癌肝転移』

2019年度日本消化器関連学会週間　(JDDW 2019)　2019年11月

別府　透：肝臓10（座長）

吉田　泰：手術と術後化学療法により5年間無再発生存中の上腸間膜静脈腫瘍塞栓を伴う進行胃癌の経験

佐藤 伸隆：画像所見の経時変化により術前診断に苦慮した肝硬化型血管腫の一例

第81回日本臨床外科学会総会　2019年11月

別府　透：総会特別企画　医師の労働環境を取り巻く社会変化と職場におけるダイバーシティ『外科医を取り巻く環境の変化と求められるダイバーシティ』

第13回肝臓内視鏡外科研究会　2019年12月

別府　透：ワークショップ 「技術認定取得に向けた各施設の取り組み」（司会）

第41回九州肝臓外科研究会　2020年1月

別府　透：AP-shuntを伴う巨大肝癌に対するTACE、lenvatinib投与後のconversion肝切除

別府　透

赤星　慎一

佐藤　伸隆

木下　浩一

First and 2nd author

1. Akahoshi S, Beppu T, Mori Y, Kinoshita K, Sato N, Kikuchi K. Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection? Hepatobiliary Surg Nutr (in press).
2. Sato N, Beppu T, Kinoshita K, Yuki H, Suyama K, Yuruki H, Motohara T, Chiyonaga S, Akahoshi S. Partial splenic embolization for lenvatinib therapy-associated thrombocytopenia among patients with hepatocellular carcinoma. Anticancer Res Dec;39(12):6895-6901
3. Sato N, Beppu T, Kinoshita K, Yuki H, Suyama K, Chiyonaga S, Motohara T, Komohara Y, Hara A, Akahoshi S. Conversion hepatectomy for huge hepatocellular carcinoma with arterioportal shunt after chemoembolization and lenvatinib therapy. Anticancer Res 2019 Oct;39(10):5695-5701.
4. Akahoshi S, Beppu T, Sato N, Kinoshita K. Is laparoscopic mesohepatectomy superior to the open approach for patients with centrally located hepatocellular carcinoma? Laparoscopic Surg 2019.
5. Kinoshita K, Beppu T, Sato N, Akahoshi S, Yuki H, Yoshida Y. Preoperative 1-week diet can markedly decrease blood loss during hepatectomy.
   Transl Gastroenterol Hepatol. 2019 Mar 26;4:20.
6. Kuramoto K, Beppu T, Irie K, Kinoshita K, Sato N, Akahoshi A, Yoshida Y, Yuki H, Hamada Y. Hepatobiliary and Pancreatic: A very rare intraductal growth type primary schwannoma of hilar bile duct. J Gastroenterol Hepatol 2019 Jun 18. doi: 10.1111/jgh.14679. [Epub ahead of print]
7. Yoshida Y, Beppu T, Kinoshita K, Sato N, Akahoshi A, Yoshida Y, Yuki H, Saito S, Kitaoka M, Nasu J. Five-year recurrence-free survival after surgery followed by oral chemotherapy for gastric cancer with portal vein tumor thrombosis. Anticancer Res 2019 Apr;39(4):2233-2238
8. Kobayashi S, Beppu T, Honda G, Yamamoto M, Takahashi K, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Sakamoto K, Yamaguchi T, Morita S, Tabuchi K, Miyazaki M, Sugihara K. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey. J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04250-9. [Epub ahead of print]
9. Miyata T, Beppu T, Imamura YU, Hayashi H, Imai K, Chikamoto A, Yamashita YI, Fukubayashi K, Ishiko T, Baba H. A 12-year recurrence-free survival after multidisciplinary treatment for a patient with combined hepatocellular-cholangiocarcinoma. Anticancer Res 2019 Apr;39(4):2139-2144

3rd author以降

1. Nitta H, Kitano Y, Miyata T, Nakagawa S, Mima K, Okabe H, Hayashi H, Imai K, Yamashita YI, Chikamoto A, Beppu T, Baba H. Validation of Functional Assessment for Liver Resection Considering Venous Occlusive Area after Extended Hepatectomy. J Gastrointest Surg. 2019 May 29. doi: 10.1007/s11605-019-04234-9. [Epub ahead of print]
2. Arima K, Nitta H, Beppu T, Nakagawa S, Okabe H, Imai K, Chikamoto A, Yamashita YI, Yamashita Y, Baba H. Impact of Repeated Hepatectomy on Liver Regeneration in Hepatocellular Carcinoma: A Propensity Score-based Analysis. Anticancer Res 2019 Feb;39(2):965-970.

英文著書

1. Beppu T, Wakabayashi G, Imai K, Yoshida Y, Baba H. Staging Classifications of Colorectal Liver Metastases, Colorectal Cancer Liver Metastases, 10.1007/978-3-030-25486-5_6, (65-85), (2019). Colorectal Cancer Liver Metastases: A Comprehensive Guide to Management, ed. by Correia MM, Springer DE

第118回 日本外科学会定期学術集会2018年4月

別府 透:SF-065 サージカルフォーラム(65)「肝臓―手術手技―1」(座長)

吉田 泰:胃切除術を施行した 80 歳以上の高齢者胃癌症例の検討

第54回 日本肝癌研究会2018年6月

別府 透:一般演題 肝切除 4(座長)

第30回日本肝胆膵外科学会2018年6月

Debate Session 4 Two-Stage Hepatectomy vs. Multiple Tumorectomy for Colorectal Liver Metastasis. (Chairman)

Kuramoto K:Assessment of liver function in hepatic venous congestion area using 99mTc-GSA SPECT/CT fused imagings

第73回 日本消化器外科学会総会2018年7月

別府 透:デジタルポスター205 肝臓:ICG 蛍光法(座長)

藏元一崇: 大腸癌肝転移切除後機能的肝再生に対する術前化学療法の影響 ―99mTc-アシアロ SPECT/CT fusion 画像での検討

木下浩一:大腸癌同時性肝転移に対する腹腔鏡下の大腸・肝同時切除例の短期 成績

入江晃士朗 (研修医):極めてまれな肝内胆管原発 神経鞘腫の1切除例
研修医奨励賞受賞

30th Anniversary IASGO World Congress, Moscow, Russian on September 9-12, 2018

別府 透:デジタルポスター205 肝臓:ICG 蛍光法(座長)

Toru Beppu: Quantification of function in hepatic venous congestion area after liver resection (invited lecture)

2018年度日本消化器関連学会週間(JDDW 2018)2018年11月

Toru Beppu:International Poster Session23 Liver: Surgery (Chairman)

藏元一崇:MRI- apparent diffusion coefficient (ADC)値による高悪性度肝細胞癌の予測.

若手奨励賞受賞

吉田 泰:腹腔鏡下低位前方切除術を施行した 80 歳以上の高齢者直腸癌症例の検討

第80回 日本臨床外科学会総会2018年11月

別府 透:ビデオワークショップ 05 安全な肝実質切離手術手技(司会)

吉田 泰:大腸癌肝転移に対する肝切除を主軸とし、腹腔鏡手術や化学療法を活用した集学的治療の導入

第31回 日本内視鏡外科学会総会2018年12月

別府 透:デジタルポスター 11肝臓 症例2座長

別府　透

吉田 泰

First and 2nd author

1. Yoshida Y, Beppu T, Kinoshita K, Sato N, Akahoshi A, Yoshida Y, Yuki H, Saito S, Kitaoka M, Nasu J. Five-year recurrence-free survival after surgery followed by oral chemotherapy for gastric cancer with portal vein tumor thrombosis. Anticancer Res (in press)
2. Kuramoto K, Beppu T, Irie K, Kinoshita K, Sato N, Akahoshi A, Yoshida Y, Yuki H, Hamada Y. A very rare intraductal growth type primary schwannoma of hilar bile duct. J Gastroenterol Hepatol (accept)
3. Kinoshita K, Beppu T, Sato N, Akahoshi A, Yuki H, Yoshida Y. Preoperative 1-week diet can markedly decrease blood loss during hepatectomy. Transl Gastroenterol Hepatol. doi: 10.21037/tgh.2019.03.08
4. Beppu T, Hayashi H, Yoshida M, Nitta H, Imai K, Okabe H, Miyata T, Higashi T, Nakagawa S, Masuda T, Hashimoto D, Miyamoto Y, Chikamoto A, Ishiko T, Shiraishi S, Yamashita Y, Baba H. Preoperative chemotherapy on functional liver regeneration for colorectal liver metastases assessed with 99mTc-GSA SPECT/CT imaging. Int Surg 102: 431-439, 2018.
5. Beppu T, Hayashi H, Miyata T, Sato N, Yoshida Y. Is laparoscopic liver resection for hepatocellular carcinoma in patients with well-preserved liver cirrhosis superior to conventional open liver resection? Laparosc Surg 2018;2:64
6. Beppu T, Kinoshita K, Miyamoto Y, Imai K, Baba H. Is laparoscopic simultaneous resection of primary colorectal cancer and liver metastases beneficial? Ann Laparosc Endosc Surg 2018;3:88.
7. Koga Y, Beppu T, Imai K, KuramotoK, Miyata T, Kitano Y, Nakagawa S, Okabe H, Okabe K, Yamashita YI, Chikamoto A, Hideo Baba. Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation. Surg Case Rep. 2018;4(1):102
8. Takeyama H,Beppu T. Higashi T, Kaida T, Arima K, Taki K, Imai K, Nitta H, Hayashi H, Nakagawa S, Okabe H, Hashimoto D, Chikamoto A, Ishiko T, Tanaka M, Sasaki Y, Baba H. Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma. Surg Today. 2018; 48(4):431-438.
9. Beppu TYamamoto M. Laparoscopic Versus Open Liver Resection for Colorectal Liver Metastases-Which Is a More Suitable Standard Practice? Ann Surg. 2018; 267:208-209.
10. Yoshida M, Beppu T, Shiraishi S, Tsuda N, Sakamoto F, Kuramoto K, Okabe H, Nitta H, Imai K, Tomiguchi S, BabaH, Yamashita Y. Liver function in areas of hepatic venous congestion after hepatectomy for liver cancer: 99mTc-GSA SPECT/CT fused imaging study. Anticancer Res 2018;38:3089- 3095.
11. Beppu T, Imai K, Kinoshita K, Yoshida Y, Baba H. Can laparoscopic liver resection for colorectal liver metastases provide early initiation of adjuvant chemotherapy? Ann Laparosc Endosc Surg 2018;3:35
12. Kinoshita K, Beppu T, Miyata T, Kuramoto K, Yoshida Y, Umesaki N, Kitano Y, Nakagawa S, Okabe H, Nitta H, Imai K, Hayashi H, Yamashita YI, Komori K, Horino K, Misumi A, Baba H. A case of 15-year recurrence- free survival after microwave coagulation therapy for liver metastasis from gastric cancer, Anticancer Res. 2018; 38(3): 1595-1598.
13. Miyata T,Beppu T,Kuramoto K, Nakagawa S, Imai K, Hashimoto D, Namimoto T, Yamashita YI, Chikamoto A, Yamashita Y, Baba H. Hepatic sclerosed hemangioma with special attention to diffusion-weighted magnetic resonance imaging. Surg Case Rep. 2018;4:3.24
14. Kuramoto K,Beppu T, Nitta H, Imai K, Masuda T, Miyata T, Koga Y, Kitano Y, Kaida T, Nakagawa S, Okabe H, Hayashi H, Hashimoto D, Yamashita YI, Chikamoto A, Kikuchi K, Baba H. Hepatic resection followed by hepatic arterial infusion chemotherapy for hepatocellular carcinoma with intrahepatic dissemination. Anticancer Res 2018;38:525-531
15. Koga Y,Beppu T. Miyata T, Kitano Y, Tsuji A, Nakagawa S, Arima K, Kuramoto K, Okabe H, Imai K, Hayashi H, Nitta H, Yamashita YI, Chikamoto A, Ishiko T, Baba H. Predicting Poorly Differentiated Hepatocellular Carcinoma that Meets the Milan Criteria. Anticancer Res. 2018;38:4093-4099.

3rd author以降

1. Arima K, Nitta H, Beppu T, Nakagawa S, Okabe H, Imai K, Chikamoto A, Yamashita YI, Yamashita Y, Baba H. Impact of Repeated Hepatectomy on Liver Regeneration in Hepatocellular Carcinoma: A Propensity Score-based Analysis. Anticancer Res. 2019 Feb;39(2):965-970.
2. Okabe H, Yoshizumi T, Yamashita YI, Imai K, Hayashi H, Nakagawa S, Itoh S, Harimoto N, Ikegami T, Uchiyama H, Beppu T, Aishima S, Shirabe K, Baba H, Maehara Y. Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma. PLoS One. 2018 Sep 14;13(9):e0203856.
3. Hidaka M, Eguchi S, Okuda K, Beppu T, Shirabe K, Kondo K, Takami Y, Ohta M, Shiraishi M, Ueno S, Nanashima A, Noritomi T, Kitahara K, Fujioka H. Impact of Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion (vp1): A Multi-institutional Study by the Kyushu Study Group of Liver Surgery. Ann Surg. 2018 Jul 24.
4. Tsukamoto M, Nitta H, Imai K, Higashi T, Nakagawa S, Okabe H, Arima K, Kaida T, Taki K, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H. Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ- carboxy prothrombin after hepatectomy for hepatocellular carcinoma. Hepatol Res. 2018 Feb;48(3):E183-E193.

第117回日本外科学会定期学術集会

古閑悠輝：肝細胞癌におけるMRI-ADC 値と臨床病理学因子の検討

藏元一崇：肝細胞癌局所凝固療法後Intrahepatic dissemination再発例の検討

別府　透：Laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching：A multi-institutional Japanese study (The 4th JSS/GSS Topic Conference)

6th Asian-Pacific Hepato-Pancreato-Biliary Association

Beppu T: Liver functional volumetry using a newly developed 99mTc-GSA SPECT/CT 3D fused imaging (Symposium)

第53回日本肝癌研究会

Beppu T: Nationwide prospective registry of laparoscopic liver resection in Japan (International Symposium)

第72回日本消化器外科学会

藏元一崇：肝硬化性血管腫の画像診断-DWI-MRI のADC 値を中心に

佐藤 伸隆：当院における高齢者大腸癌患者に対する術後補助化学療法

別府 透：Hanging maneuver を併用した前方肝切除は大型肝細胞癌の予後を改善する（シンポジウム）

第25回　日本消化器関連学会週間（JDDW 2017）

古閑悠輝：ミラノ基準内肝細胞癌における分化度予測と治療法選択

藏元一崇：大腸癌肝転移に対する腹腔鏡下肝切除の有用性―傾向スコアマッチング論文による開腹肝切除との比較

木下浩一：食道癌における腫瘍のCT値を用いた術前化学放射線療法の効果予測 おもな診療領域

IASGO (International Association of Surgeons, Gastroenterologists and Oncologists) World Congress 2017

Beppu T: Anterior approach with hanging maneuver for hepatocellular carcinoma: A multi-institutional propensity score-matching study (invited lecture)

第39回九州肝臓外科研究会

藏元一崇：中規模病院における肝腫瘍に対する腹腔鏡下肝切除の導入

別府　透：肝悪性腫瘍に対する腹腔鏡下肝切除の有用性―傾向スコアマッチングやランダム化比較試験による検証（基調講演）

九州外科学会

別府　透：肝臓2（コメンテーター）

九州大腸肛門病学会

別府　透：切除不能大腸癌に対するConversion therapyの現状（コメンテーター）

藏元一崇

別府　透

First and 2nd author

1. Kinoshita K, Beppu T, Miyata T, Kuramoto K, Yoshida Y, Umesaki N, Kitano Y, Nakagawa S, Okabe H, Nitta H, Imai K, Hayashi H, Yamashita YI, Komori K, Horino K, Misumi A, Baba H. A case of 15-year recurrence-free survival after microwave coagulation therapy for liver metastasis from gastric cancer. Anticancer Res 2018; 38(3): 1595-1598.
2. Kuramoto K, Beppu T, Nitta H, Imai K, Masuda T, Miyata T, Koga Y, Kitano Y, Kaida T, Nakagawa S, Okabe H, Hayashi H, Hashimoto D, Yamashita YI, Chikamoto A, Kikuchi K, Baba H. Hepatic resection followed by hepatic arterial infusion chemotherapy for hepatocellular carcinoma with intrahepatic dissemination. Anticancer Res 2018 Jan;38(1):525-531
3. Koga Y, Beppu T, Kuramoto K, Kinoshita K, Yoshida Y, Imai K, Takahara T, Nakamura M, Wakabayashi G, Baba H. Comparison of laparoscopic versus open liver resection for hepatocellular carcinoma using propensity score matching. Ann Laparosc Endosc Surg 2017; 2.
4. Beppu T, Imai K, Kinoshita K, Yoshida Y, Baba H. Can laparoscopic liver resection for colorectal liver metastases provide early initiation of adjuvant chemotherapy? Ann Laparosc Endosc Surg 2018;3:35
5. Beppu T, Yamamoto M. Laparoscopic Versus Open Liver Resection for Colorectal Liver Metastases-Which Is a More Suitable Standard Practice? Ann Surg 2018 Feb;267(2):208-209.
6. Beppu T, Hayashi H, Yoshida M, Nitta H, Imai K, Okabe H, Miyata T, Higashi T, Nakagawa S, Masuda T, Hashimoto D, Miyamoto Y, Chikamoto A, Ishiko T, Shiraishi S, Yamashita Y, Baba H. Preoperative chemotherapy on functional liver regeneration for colorectal liver metastases assessed with 99mTc-GSA SPECT/CT imaging. Int Surg (in press)
7. Beppu T, Nakagawa S, Nitta H, Okabe H, Kaida T, Imai K, Hayashi H, Koga Y, Kuramoto K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Baba H. The Number of positive tumor marker status is beneficial for the selection of therapeutic modalities in patients with hepatocellular carcinoma. J Clin Transl Hepatol 2017 Jun 28;5(2):165-168.
8. Beppu T, Imai K, Okuda K, Eguchi S, Kitahara K, Taniai N, Ueno S, Shirabe K, Ohta M, Kondo K, Nanashima A, Noritomi T, Shiraishi M, Takami Y, Okamoto K, Kikuchi K, Baba H, Fujioka H. Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study. J Hepatobiliary Pancreat Sci 2017 Mar;24(3):127-136.
9. Beppu T, Imai K, Sakamoto Y,Miyamoto Y, Baba H. Comparison of laparoscopic versus open liver resection for colorectal liver metastases using propensity score matching. Ann Laparosc Endosc Surg 2017; 1: 50.
10. Yoshida M, Beppu T, Shiraishi S, Tsuda N, Sakamoto F, Kuramoto K, Okabe H, Nitta H, Imai K, Tomiguchi S, Baba H, Yamashita Y. Liver function in areas of hepatic venous congestion after hepatectomy for liver cancer: 99mTc-GSA SPECT/CT fused imaging study. Anticancer Res (in press)
11. Miyata T, Beppu T, Kuramoto K, Nakagawa S, Imai K, Hashimoto D, Namimoto T, Yamashita YI, Chikamoto A, Yamashita Y, Baba H.　Hepatic sclerosed hemangioma with special attention to diffusion-weighted magnetic resonance imaging. Surg Case Rep 2018; 4(1):3.
12. Miyata T, Beppu T, Higashi T, Nakagawa S, Okabe H, Imai K, Yamashita YI, Chikamoto A, Baba H. A Glissonean Approach with Individual Isolation During Right Hemi-Hepatectomy After Portal Vein Embolization. Anticancer Res 2017;37(12):7069-7071.
13. Takeyama H, Beppu T. Higashi T, Kaida T, Arima K, Taki K, Imai K, Nitta H, Hayashi H, Nakagawa S, Okabe H, Hashimoto D, Chikamoto A, Ishiko T, Tanaka M, Sasaki Y, Baba H.　Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma. Surg Today 2018; 48(4): 431-438.

3rd author以降

1. Sakamoto K, Honda G, Beppu T, Kotake K, Yamamoto M, Takahashi K, Endo I, Hasegawa K, Itabashi M, Hashiguchi Y, Kotera Y, Kobayashi S, Yamaguchi T, Morita S, Miyazaki M, Sugihara K; Joint Committee for Nationwide Survey on Colorectal Liver Metastasis.　Comprehensive data of 3,820 patients newly diagnosed with colorectal liver metastasis between 2005 and 2007: report of a nationwide survey in Japan. J Hepatobiliary Pancreat Sci 2018; 25: 115–123.
2. Yamashita Y, Shirabe K, Beppu T, Eguchi, S, Nanashima A, Ohta M, Ueno S, Kondo K, Kitahara K, Shiraishi M, Takami Y, Noritomi T, Okamoto K, Ogura Y, Baba H, Fujioka H. Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the Kyushu Study Group of Liver Surgery. Ann Gastroenterol Surg 2017;1:136–142.
3. Yagi T, Hashimoto D, Taki K, Yamamura K, Chikamoto A, Ohmuraya M, Beppu T, Baba H. Surgery for metastatic tumors of the pancreas. Surg Case Rep 2017 Dec;3(1):31. doi: 10.1186/s40792-017-0308-0. Epub 2017 Feb 18.
4. Kaibori M, Kon M, Kitawaki T, Kawaura T, Hasegawa K, Kokudo N, Ariizumi S, Beppu T, Ishizu H, Kubo S, Kamiyama T, Takamura H, Kobayashi T, Kim DS, Wang HJ, Kim JM, Han DH, Park SJ, Kang KJ, Hwang S, Roh Y, You YK, Joh JW, Yamamoto M.　Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2017 Nov;24(11):616-626.
5. Tsukamoto M, Nitta H, Imai K, Higashi T, Nakagawa S, Okabe H, Arima K, Kaida T, Taki K, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H. Clinical significance of half-lives of tumor markers fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma. Hepatol Res 2018 Feb;48(3):E183-E193.
6. Taki K, Hashimoto D, Nakagawa S, Ozaki N, Tomiyasu S, Ohmuraya M, Arima K, Kaida T, Higashi T, Sakamoto K, Sakata K, Okabe H, Nitta H, Hayashi H, Chikamoto A, Beppu T, Takamori H, Hirota M, Baba H. Significance of lymph node metastasis in pancreatic neuroendocrine tumor. Surg Today 2017 Sep;47(9):1104-1110.
7. Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, Taki K, Nakagawa S, Okabe H, Hayashi H, Imai K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Beppu T, Baba H. Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma. Hepatol Res 2017 Sep;47(10):991-999.
8. Arima K, Okabe H, Hashimoto D, Chikamoto A, Nitta H, Higashi T, Kaida T, Yamamura K, Kitano Y, Komohara Y, Yamashita YI, Beppu T, Takeya M, Baba H. Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors. Int J Clin Oncol 2017 Aug;22(4):734-739.
9. Okabe H, Hashimoto D, Chikamoto A, Yoshida M, Taki K, Arima K, Imai K, Tamura Y, Ikeda O, Ishiko T, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Yamashita YI, Yoshizumi T, Beppu T, Yamashita Y, Baba H, Maehara Y. Shape and Enhancement Characteristics of Pancreatic Neuroendocrine Tumor on Preoperative Contrast-enhanced Computed Tomography May be Prognostic Indicators. Ann Surg Oncol 2017 May;24(5):1399-1405.
10. Nitta H, Nakagawa S, Kaida T, Arima K, Higashi T, Taki K, Okabe H, Hayashi H, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H. Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma. Surg Today 2017 Mar;47(3):375-384.

第116回　日本外科学会定期学術集会

古閑悠輝　外科的治療を要したイレウス症例の検討

藏元一崇　急性胆石性胆嚢炎に対して腹腔鏡下手術と開腹術を施行した症例の比較検討

別府 透　進行肝細胞癌に対する外科治療を主軸としたstrategy―適応と長期予後（パネルディスカッション）

第28回　日本肝胆膵外科学会

Beppu T. Utility of portal vein embolization followed by right-side hemihepatectomy for hepatocellular carcinoma:

a multi-institutional study (International workshop)

Beppu T. Long-term and perioperative outcomes of laparoscopic vs open liver resection for colorectal liver metastases using propensity score matching: a JSHBPS project study (Project Study)

第71回　日本消化器外科学会

古閑悠輝　超高齢者大腸癌手術における安全性の検討

Beppu T. Induction of RFA and endoscopic hepatectomy to the treatment strategy for small HCC (Panel discussion)

第24回　日本消化器関連学会週間（JDDW 2016）

古閑悠輝　傾向スコアマッチングを用いた大腸癌手術の検討（開腹vs腹腔鏡）

藏元一崇　上部消化管癌性閉塞に対するステント留置の検討

第182回　熊本外科集談会

古閑悠輝　肝動脈化学塞栓療法と門脈結紮術で臨床的CRとなった進行肝細胞癌の経験

第78回　日本臨床外科学会総会

古閑悠輝　多発大腸癌肝転移は導入化学療法後肝切除の良い適応である

別府 透　大腸癌肝転移のConversion Therapy – up to date（パネルディスカッション）

第89回　日本胃癌学会総会

古閑悠輝　FBXW7 expression in GIST: its clinical significance

第35回　Microwave Surgery研究会

古藏元一崇　肝細胞癌局所凝固療法後Intrahepatic dissemination再発の治療成績

The 25th APASL (Asian Pacific Association for the Study of the Liver)

Beppu T. Portal vein embolization (PVE) followed by right-side hemihepatectomy for hepatocellular carcinoma (HCC)

IASGO (International Association of Surgeons, Gastroenterologists and Oncologists) World Congress 2016

Beppu T. Laparoscopic versus Open Liver Resection for Liver Tumor: A Multi-institutional Japanese Study (Invited lecture)

1. Beppu T. Portal vein embolization followed by right-side hemihepatectomy for hepatocellular carcinoma patients: A Japanese multi-institutional Study. J Am Coll Surg. 2016; 222: 1138-1148.
2. Beppu T. Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: A multi-Institutional propensity score-matching study. J Hepatobiliary Pancreat Sci. (in press)
3. Beppu T. Comparison of laparoscopic versus open liver resection for colorectal liver metastases using propensity score matching. Ann Laparosc Endosc Surg. 2017; 1: 50.